Personal tools

MCL coexpression mm9:2445: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|coexpression_dpi_cluster_scores_median=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0234784353458152,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.202273057887734,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0359524240942892,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.149563586761194,0.467776638263798,0,0,0,0,0,0.0378146482960409,0,0.37454222072415,0.272860837237969,0.189443698639862,0.13867729912934,0.139241831090348,0,0.0727974683912195,0,0,0,0,0,0.065276089799087,0,0,0,0,0,0,0,0,0,0,0,0,0.0326283328848338,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.163983444546134,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.36688061805648,0,0,0.166870366647121,0.156966505976237,0.424894435882505,1.566486319823,2.11002408382472,1.84594955091218,0.703665429996727,0.782345435269382,0.621539955332095,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.155279183100254,0,0,0,0,0,0,0,0,0,0,0.145536792418273,0,0,0,0,0,0.456251591810896,0.0332201611339675,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.179844365653835,0,0,0
|coexpression_dpi_cluster_scores_median=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0234784353458152,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.202273057887734,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0359524240942892,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.149563586761194,0.467776638263798,0,0,0,0,0,0.0378146482960409,0,0.37454222072415,0.272860837237969,0.189443698639862,0.13867729912934,0.139241831090348,0,0.0727974683912195,0,0,0,0,0,0.065276089799087,0,0,0,0,0,0,0,0,0,0,0,0,0.0326283328848338,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.163983444546134,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.36688061805648,0,0,0.166870366647121,0.156966505976237,0.424894435882505,1.566486319823,2.11002408382472,1.84594955091218,0.703665429996727,0.782345435269382,0.621539955332095,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.155279183100254,0,0,0,0,0,0,0,0,0,0,0.145536792418273,0,0,0,0,0,0.456251591810896,0.0332201611339675,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.179844365653835,0,0,0
|gostat_on_MCL_coexpression=GO:0004263;chymotrypsin activity;0.013878997059844;73626!GO:0004295;trypsin activity;0.013878997059844;73626!GO:0007586;digestion;0.013878997059844;73626!GO:0004252;serine-type endopeptidase activity;0.0345240051863621;73626!GO:0008236;serine-type peptidase activity;0.0345240051863621;73626!GO:0017171;serine hydrolase activity;0.0345240051863621;73626!
|gostat_on_MCL_coexpression=GO:0004263;chymotrypsin activity;0.013878997059844;73626!GO:0004295;trypsin activity;0.013878997059844;73626!GO:0007586;digestion;0.013878997059844;73626!GO:0004252;serine-type endopeptidase activity;0.0345240051863621;73626!GO:0008236;serine-type peptidase activity;0.0345240051863621;73626!GO:0017171;serine hydrolase activity;0.0345240051863621;73626!
|ontology_enrichment_celltype=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0001264!1.25e-25!12;UBERON:0002075!1.81e-15!19;UBERON:0000160!1.30e-09!31;UBERON:0005409!1.39e-09!47;UBERON:0002323!5.23e-07!37;UBERON:0004458!5.23e-07!37;UBERON:0003886!8.95e-07!38
}}
}}

Revision as of 18:29, 11 October 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr6:40914759..40914780,+p1@1810009J06Rik
Mm9::chr6:40949465..40949467,-p2@Gm2663
Mm9::chr6:40949478..40949497,-p1@Gm2663
Mm9::chr9:95093341..95093345,+p@chr9:95093341..95093345
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:0004263chymotrypsin activity0.013878997059844
GO:0004295trypsin activity0.013878997059844
GO:0007586digestion0.013878997059844
GO:0004252serine-type endopeptidase activity0.0345240051863621
GO:0008236serine-type peptidase activity0.0345240051863621
GO:0017171serine hydrolase activity0.0345240051863621



Relative expression of the co-expression cluster over median <br>Analyst:




Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>

Uber Anatomy
Ontology termp-valuen
pancreas1.25e-2512
viscus1.81e-1519
intestine1.30e-0931
gastrointestinal system1.39e-0947
body cavity5.23e-0737
body cavity or lining5.23e-0737
body cavity precursor8.95e-0738


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=MCL_coexpression_mm9:2445&oldid=2154672"